1)Christiansen CF, Johansen MB, Langeberg WJ, et al:Incidence of acute kidney injury in cancer patients:a Danish population-based cohort study. Eur J Intern Med 22:399-406, 2011
2)Salahudeen AK, Doshi SM, Pawar T, et al:Incidence rate, clinical correlates, and outcomes of AKI in patients admitted to a comprehensive cancer center. Clin J Am Soc Nephrol 8:347-354, 2013
3)Lam AQ and Humphreys BD:Onco-nephrology:AKI in the cancer patient. Clin J Am Soc Nephrol 7:1692-1700, 2012
4)Birkeland SA and Storm HH:Glomerulonephritis and malignancy:a population-based analysis. Kidney Int 63:716-721, 2003
5)Bjorneklett R, Vikse BE, Svarstad E, et al:Long-term risk of cancer in membranous nephropathy patients. Am J Kidney Dis 50:396-403, 2007
6)Perazella MA:Onco-nephrology:renal toxicities of chemotherapeutic agents. Clin J Am Soc Nephrol 7:1713-1721, 2012
7)Eremina V, Jefferson JA, Kowalewska J, et al:VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358:1129-1136, 2008
8)De Stefano A, Carlomagno C, Pepe S, et al:Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patients. Cancer Chemother Pharmacol 68:1207-1213, 2011
9)Rixe O, Billemont B and Izzedine H:Hypertension as a predictive factor of Sunitinib activity. Ann Oncol 18:1117, 2007
10)Kitai Y, Matsubara T and Yanagita M:Onco-nephrology:current concepts and future perspectives. Jpn J Clin Oncol, 2015, in press
11)Sahni V, Choudhury D and Ahmed Z:Chemotherapy-associated renal dysfunction. Nat Rev Nephrol 5:450-462, 2009
12)Lameire N, Van Biesen W and Vanholder R:Electrolyte disturbances and acute kidney injury in patients with cancer. Semin Nephrol 30:534-547, 2010
13)Maisonneuve P, Agodoa L, Gellert R, et al:Cancer in patients on dialysis for end-stage renal disease:an international collaborative study. Lancet 354:93-99, 1999
14)Holley JL:Screening, diagnosis, and treatment of cancer in long-term dialysis patients. Clin J Am Soc Nephrol 2:604-610, 2007
15)Merchan, JR:Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency, In:UpToDate, Drews RE(Ed), UpToDate, Waltham, MA. http://www.uptodate.com/
16)Janus N, Launay-Vacher V, Thyss A, et al:Management of anticancer treatment in patients under chronic dialysis:results of the multicentric CANDY(CANcer and DialYsis)study. Ann Oncol 24:501-507, 2013
17)Janus N, Thariat J, Boulanger H, et al:Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients. Ann Oncol 21:1395-1403, 2010
18)米澤 淳,中川俊作,松原和夫:血液透析における抗癌剤除去を—TDMの必要性.腎臓内科・泌尿器科1:80-83,2015